Trademark: 85021985
Word
GLYBERA
Status Date
Friday, October 26, 2018
Registration Number
4113673
Registration Date
Tuesday, March 20, 2012
Filing Date
Friday, April 23, 2010
Published for Opposition
Tuesday, January 3, 2012
Cancellation Date
Friday, October 26, 2018
5 Pharmaceutical preparations and substances for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy vectors; biological preparations for medical use; biological preparations for medical use, namely, metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, namely, vaccines and prophylaxis products for use in nuclei acid-based therapy, gene therapy and cell therapy; gene and nucleic acid modulation for the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene; gene therapy and prophylaxis products, namely, gene delivery and gene transfer for the treatment of metabolic disorders and disorders which are the result of one or more mutations within the lipoprotein lipase gene; all the aforementioned goods used exclusively in the treatment of metabolic disorders and disorders which are a result of one or more mutations within the lipoprotein lipase gene
44 Medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders through gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation
Color is not claimed as a feature of the mark.
The mark consists of the word "Glybera" with a dot in the letter "G".
Oct 26, 2018
Cancelled Sec. 8 (6-Yr)
Mar 20, 2017
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 5, 2014
Assignment Of Ownership Not Updated Automatically
Feb 12, 2014
Automatic Update Of Assignment Of Ownership
Mar 20, 2012
Registered-Principal Register
Jan 3, 2012
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2012
Published For Opposition
Dec 14, 2011
Notification Of Notice Of Publication E-Mailed
Nov 28, 2011
Law Office Publication Review Completed
Nov 22, 2011
Approved For Pub - Principal Register
Nov 22, 2011
Examiner's Amendment Entered
Nov 21, 2011
Notification Of Examiners Amendment E-Mailed
Nov 21, 2011
Examiners Amendment E-Mailed
Nov 21, 2011
Examiners Amendment -Written
Nov 4, 2011
Teas/Email Correspondence Entered
Nov 4, 2011
Correspondence Received In Law Office
Nov 4, 2011
Teas Response To Office Action Received
May 18, 2011
Notification Of Non-Final Action E-Mailed
May 18, 2011
Non-Final Action E-Mailed
May 18, 2011
Non-Final Action Written
Apr 13, 2011
Teas/Email Correspondence Entered
Apr 13, 2011
Correspondence Received In Law Office
Apr 13, 2011
Teas Response To Office Action Received
Feb 14, 2011
Notification Of Non-Final Action E-Mailed
Feb 14, 2011
Non-Final Action E-Mailed
Feb 14, 2011
Non-Final Action Written
Jan 18, 2011
Teas/Email Correspondence Entered
Jan 18, 2011
Correspondence Received In Law Office
Jan 11, 2011
Assigned To Lie
Dec 20, 2010
Teas Response To Office Action Received
Jun 23, 2010
Notification Of Non-Final Action E-Mailed
Jun 23, 2010
Non-Final Action E-Mailed
Jun 23, 2010
Non-Final Action Written
Jun 22, 2010
Assigned To Examiner
Apr 29, 2010
Notice Of Design Search Code Mailed
Apr 28, 2010
New Application Office Supplied Data Entered In Tram
Apr 27, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
